Evidence map›Paper›PMID 40374810›Full record

ArticleLeukemia2025

Correction: Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody.

Marc S Raab, Yael C Cohen, Fredrik Schjesvold, Kimberly Aardalen, Adwait Oka, Andrew Spencer, Martin Wermke, Anita D Souza, Jonathan L Kaufman, Anna Maria Cafro and 14 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Marc S Raab *Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-4181-6922
Yael C Cohen *Department of Hematology, Tel-Aviv Sourasky (Ichilov) Medical Center, Tel Aviv University, Tel Aviv, Israel.ORCID http://orcid.org/0000-0002-9061-7287
Fredrik Schjesvold *Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0003-1096-0569
Kimberly AardalenNovartis Institutes for BioMedical Research, Cambridge, MA, USA.
Adwait OkaNovartis Institutes for BioMedical Research, Cambridge, MA, USA.
Andrew SpencerDepartment of Malignant Haematology, The Alfred Hospital, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-0531-7424
Martin WermkeNCT/UCC Early Clinical Trial Unit, Universitätsklinikum Carl Gustav Carus an der Technische Universität, Dresden, Germany.ORCID http://orcid.org/0000-0002-4844-4087
Anita D SouzaDivision of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-1092-5643
Jonathan L KaufmanWinship Cancer Institute, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-5687-6429
Anna Maria CafroDepartment of Hematology, Niguarda Hospital, Niguarda, Milan, Italy.
Enrique M OcioHospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.ORCID http://orcid.org/0000-0002-5765-0085
Noriko DokiHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Kristin HensonNovartis Institutes for BioMedical Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-9305-6868
Gina TrabuccoNovartis Institutes for BioMedical Research, Cambridge, MA, USA.
Ana CarrionNovartis Institutes for BioMedical Research, Cambridge, MA, USA.
Florent C BenderNovartis Institutes for BioMedical Research, Basel, Switzerland.
Pierre-Eric JuifNovartis Institutes for BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0002-4899-8768
Adonai FessehatsionNovartis Institutes for BioMedical Research, Cambridge, MA, USA.
Liqiong FanNovartis Institutes for BioMedical Research, Cambridge, MA, USA.
Jeffrey P StonehouseNovartis Institutes for BioMedical Research, Cambridge, MA, USA.
John W BlankenshipNovartis Institutes for BioMedical Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4192-7059
Brian GrandaNovartis Institutes for BioMedical Research, Cambridge, MA, USA.
Serena De VitaNovartis Institutes for BioMedical Research, Cambridge, MA, USA. serena.de_vita@novartis.com.ORCID http://orcid.org/0009-0000-8140-9585
Haihui LuNovartis Institutes for BioMedical Research, Cambridge, MA, USA. haihui.lu@novartis.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40374810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.